‘Unsavoury’ Practices: Pharma Will Need To Be More Transparent On CME Expenses In India

Faces Audits Under Revised Rules

India's revised code for pharma marketing practices outlines guidelines for CME programs • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from India

More from Asia